A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2018-09-05
- Last Posted Date
- 2019-01-04
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 105
- Registration Number
- NCT03657719
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102
- Conditions
- Interventions
- First Posted Date
- 2018-05-08
- Last Posted Date
- 2020-01-30
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 186
- Registration Number
- NCT03519113
- Locations
- 🇰🇷
Seoul Asan Medical Center, Seoul, Korea, Republic of
Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency
- First Posted Date
- 2018-04-10
- Last Posted Date
- 2020-07-07
- Lead Sponsor
- Green Cross Corporation
- Registration Number
- NCT03492710
A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2018-03-06
- Last Posted Date
- 2022-03-03
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 53
- Registration Number
- NCT03454620
- Locations
- 🇰🇷
Seoul National Universtiy Hosipital, Seoul, Korea, Republic of
🇰🇷Chonnam National University Hwasun Hospital, Chŏnam, Korea, Republic of
🇰🇷National Cancer Center, Gyeonggi-do, Korea, Republic of
A Study of MG1111 in Healthy Children
- First Posted Date
- 2017-12-18
- Last Posted Date
- 2021-05-14
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 814
- Registration Number
- NCT03375502
- Locations
- 🇰🇷
The catholic university of Korea, Seoul st. mary's hospital, Banpo-dong, Seoul, Korea, Republic of
Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults
- First Posted Date
- 2017-12-06
- Last Posted Date
- 2017-12-18
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT03363178
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults
- Conditions
- Interventions
- First Posted Date
- 2017-11-29
- Last Posted Date
- 2018-11-19
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT03357263
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age
- Conditions
- Interventions
- First Posted Date
- 2017-09-18
- Last Posted Date
- 2017-09-18
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 260
- Registration Number
- NCT03285997
- Locations
- 🇰🇷
The Catholic Univ.of Korea Seoul St.Mary's Hospital, Seoul, Korea, Republic of
A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older
- First Posted Date
- 2016-09-28
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 274
- Registration Number
- NCT02917304
- Locations
- 🇰🇷
Soon Chun Hyang University Bucheon Hospital, Gyeonggi-do, Korea, Republic of
🇰🇷The Catholic Univ. of Korea Daejeon St.Mary's Hospital, Daejeon, Korea, Republic of
🇰🇷The Catholic Univ.of Korea Uijeongbu St.Mary's Hospital, Gyeonggi-do, Korea, Republic of
A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults
- Conditions
- Interventions
- First Posted Date
- 2016-09-27
- Last Posted Date
- 2016-09-29
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 414
- Registration Number
- NCT02915809